RESEARCH ARTICLE
www.advmat.de
Lab-in-Cell:ACovalentPhotosensitizerReversesHypoxia
andEvokesFerroptosisandPyroptosisforEnhanced
Anti-TumorImmunity
Bingnan Wang, Guiquan Zhang, Zhizai Chen, Hanchen Shen, Chunyang Li, Jianqing Li,
Meixi Yi, Jianwei Sun, Ryan T. K. Kwok,* Jacky W. Y. Lam,* Anjun Qin,*
and Ben Zhong Tang*
Photodynamicimmunotherapypresentsanon-invasivestrategycharacterized
byspatiotemporalcontrolandminimalsideeÔ¨Äectstoinduceimmunogenic
celldeath(ICD).ThisapproachsigniÔ¨Åcantlyenhancesthereleaseof
tumor-associatedantigensanddamage-associatedmolecularpatterns,
therebyimprovingcancerimmunotherapyoutcomes.However,hypoxiaand
antioxidantdefensesattumorsitesconsiderablydiminishtheeÔ¨Écacyof
photodynamicimmunotherapy.Inthiswork,acovalentwarhead,
alkyneamide,isintroducedintoanAIEphotosensitizertodevelopanovel
covalentphotosensitizer,MBTP-PA,whichtargetsredoxsystemsand
facilitatesferroptosis-andpyroptosis-mediatedphotodynamic
immunotherapybythiol-yneclickreactions.Thecovalentphotosensitizer
interactswithintracellularthiolcompoundssuchascysteineandglutathione,
disruptingtheintracellularantioxidantsystemandalleviatinghypoxia.This
resultsinenhancedphotodynamictherapy(PDT)eÔ¨Écacycomparedtothe
non-covalentphotosensitizerMBTP-A.Furthermore,inconjunctionwithPDT,
thisreactiontherapycanactivateICDthroughferroptosisandpyroptosis,
therebyenhancinganti-tumorimmunity.Notably,invivoinjectionof
MBTP-PAnanoparticlesatthetumorsiteledtotheeliminationofprimary
tumors,inhibitingdistaltumorsandexhibitingminimalsideeÔ¨Äects.
Therefore,thisworknotonlyintegratesthethiol-yneclickreactionsinto
cellularsystems,signiÔ¨ÅcantlyenhancingtheeÔ¨Écacyofphotodynamic
immunotherapybutalsopavesthewayfordevelopingnovelphotosensitizers.
B.Wang,H.Shen,J.Sun,R.T.K.Kwok,J.W.Y.Lam,B.Z.Tang
DepartmentofChemistry
theHongKongBranchofChineseNationalEngineeringResearchCentre
forTissueRestorationandReconstruction
DepartmentofChemicalandBiologicalEngineering
DivisionofLifeScience
andStateKeyLaboratoryofMolecularNeuroscience
TheHongKongUniversityofScience&Technology
ClearWaterBay,Kowloon,HongKong999077,China
E-mail:chryan@ust.hk;chjacky@ust.hk;tangbenz@cuhk.edu.cn
The ORCID identiÔ¨Åcation number(s) for the author(s) of this article
canbefoundunder https://doi.org/10.1002/adma.202415673
DOI:10.1002/adma.202415673
1.Introduction
Cancer immunotherapy is a rapidly
evolving Ô¨Åeld that harnesses the pa-
tient‚Äôs immune system to combat ma-
lignant tumors, [1‚Äì5] oÔ¨Äering innovative
strategies alongside traditional thera-
pies such as surgery, chemotherapy, and
radiotherapy.[6,7] A critical step in tumor
immunotherapy is achieving eÔ¨Écient im-
munogenic cell death (ICD).[8,9] During
ICD, the release of damage-associated
molecular patterns (DAMPs), including
calreticulin(CRT)andhighmobilitygroup
box 1 (HMGB1), promotes the matura-
tion of dendritic cells (DCs) and T cell
diÔ¨Äerentiation, activates the immune re-
sponse, and initiates adaptive antitumor
immunity.[10,11] Recently, evidence increas-
ingly suggests that an immune response
is elicited following photodynamic therapy
(PDT), highlighting its potential as an
immunogenic treatment approach. [12‚Äì14]
PDT is a non-invasive treatment that
oÔ¨Äers spatiotemporal control by utilizing
photosensitizers to produce singlet oxygen
(1O2) through energy transfer (Type II) or
other reactive oxygen species (ROS) via
G.Zhang,C.Li,J.Li,M.Yi,A.Qin
StateKeyLaboratoryofLuminescentMaterialsandDevices
GuangdongProvincialKeyLaboratoryofLuminescencefromMolecular
Aggregates
CenterforAggregation-InducedEmission
AIEInstitute
SouthChinaUniversityofTechnology
Guangzhou510640,China
E-mail:msqinaj@scut.edu.cn
Z.Chen
DepartmentofGynecology
GuangdongProvincialPeople‚ÄôsHospital
(GuangdongAcademyofMedicalSciences)
SouthernMedicalUniversity
Guangzhou510080,China
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(1of14)
www.advancedsciencenews.com www.advmat.de
electron transfer (Type I) when exposed to light, eÔ¨Äectively de-
stroying tumor tissue.[15‚Äì21] During PDT, cells undergo the pro-
cess of ICD, releasing DAMPs, and activating the systemic
adaptive immune response.[22‚Äì24] However, the immune eÔ¨Äects
elicited by PDT-induced ICD are inÔ¨Çuenced by several factors,
which can lead to suboptimal outcomes in immunotherapy.[9,25]
PDT should be combined with immune checkpoint blockade
reagentstoachieveabetteranti-tumorimmuneeÔ¨Äect. [26,27] The
primaryfactorsaÔ¨ÄectingeÔ¨Écacyinclude:1)thelimitedresidence
timeof photosensitizers in tumorcells, resultingin insuÔ¨Écient
enrichment;[28] 2) hypoxia and the tumor‚Äôs antioxidant system,
which diminish the eÔ¨Äectiveness of PDT;[29,30] and 3) the ten-
dencyofPDTtoinduceapoptosis,whichisnotconducivetothe
releaseofDAMPs. [14] Therefore,toachievehighlyeÔ¨Äectiveanti-
tumor immunity, it is crucial to develop long-lasting photosen-
sitizers that can alleviate tumor hypoxia and antioxidant system
whileeÔ¨ÄectivelyinducingICD.
To enhance the eÔ¨Écacy of PDT, strategies such as designing
Type I photosensitizers and developing oxygen-carrying meth-
ods to increase tumor oxygen levels have been explored.[31‚Äì35]
However,simplyboostingtheoxidativecapacityofPDTisinade-
quate,asrobustantioxidantresponsesintumorcellscansignif-
icantly diminishits eÔ¨Äectiveness.[36] Malignant tumorsthatsur-
vivetheseresponsesmaydeveloptolerancetoPDT. [37] Therefore,
it is essential to develop photosensitizers that speciÔ¨Åcally target
redoxsystemstoimprovePDTeÔ¨Écacy.Inorganicchemistry,ac-
tivatedalkyneandthiolclickreactionshavebeendevelopedand
successfullyappliedinpolymersynthesis, 3Dprinting,andbio-
conjugation,owingtotheirmildreactionconditions,speciÔ¨Åcity,
andhigheÔ¨Éciency.[38‚Äì40] Thiolcompoundssuchascysteine(Cys)
andglutathione(GSH),playacriticalroleasintracellularantiox-
idantsinmaintainingredoxbalance. [41] Byincorporatinganacti-
vatedalkyneintophotosensitizersasacovalentwarhead,aclick
reaction can occur between the alkyne and thiol groups within
cells.Thisreactionconsumesreducingsubstancesandenhances
theoxidationstate,therebysigniÔ¨ÅcantlyimprovingtheeÔ¨Äective-
nessofPDT.Additionally,thisclickreactioncouldstimulateim-
muneresponsesandprolongtheresidencetimeofthephotosen-
sitizeratthelesionsite,resultinginmoreeÔ¨ÄectivePDT-mediated
immunotherapy.
Aggregation-induced emission (AIE) photosensitizers exhibit
superior ROS production eÔ¨Éciency in aggregated states com-
pared to traditional photosensitizers.[42‚Äì47] To leverage this ad-
vantage, we incorporated the covalent warhead alkynamide into
an AIE photosensitizer, developing an endoplasmic reticulum-
targeting covalent photosensitizer MBTP-PA, aimed at alleviat-
ing hypoxia and evoking ferroptosis- and pyroptosis-mediated
immunotherapy.Alkynamidereactswiththiolcompoundssuch
as Cys, GSH, and proteins, forming covalent bonding with in-
tracellular substances and extending the retention time of the
photosensitizer(Scheme1A).Thisintracellularreactionnotonly
alleviates hypoxia but also induces oxidative stress in cells, re-
sulting in improved PDT eÔ¨Écacy. In addition, following reac-
B.Z.Tang
SchoolofScienceandEngineering
ShenzhenInstituteofAggregateScienceandTechnology
TheChineseUniversityofHongKong
Shenzhen518172,China
tion therapy and PDT, ferroptosis and pyroptosis are induced,
leading to the release of a series of inÔ¨Çammatory factors and
DMAPs. These factors stimulate the maturation and antigen-
presentingabilityofDCsandactivatetheTcells-dependentadap-
tive immune response. This systemic anti-tumor immunity ef-
fectivelydestroysprimarytumorsandeÔ¨Äectivelyinhibitsdistant
tumors (Scheme1B). Therefore, this work not only develops a
covalent AIE photosensitizer to alleviate hypoxia and promote
ferroptosis- and pyroptosis-mediated immunotherapy but also
provides a framework for discovering new materials to enhance
anti-tumorresponses.
1.1.PhotophysicalProperties
MBTP-PA with alkynamide was synthesized by re-
acting MBTP-A with propargylic acid in the pres-
ence of 4-Dimethylaminopyridine (DMAP) and 1-(3-
Dimethylaminopropyl)-3-ethylcarbodiimide (EDC). Its structure
was conÔ¨Årmed using13CN M R ,1H NMR, and high-resolution
mass spectrometry (Figure 1A;F i g u r e sS1‚ÄìS3, Supporting
Information). The photophysical properties of MBTP-PA were
initially examined. The UV‚Äìvis spectra revealed an absorption
peak (ùúÜabs) at 463 nm in a dilute DMSO solution (Figure1B).
As depicted in photoluminescence (PL) spectra (Figure1C), the
emission peaks of MBTP-PA in solid Ô¨Ålm and DMSO solution
were 652 and 666 nm, respectively. Furthermore, the AIE eÔ¨Äect
of MBTP-PA in DMSO/H2O mixtures was investigated because
MBTP-PA is soluble in DMSO but not in H2O. As shown
in Figure 1D,E, increasing the water fraction (fw)i nD M S O
signiÔ¨Åcantly enhanced the Ô¨Çuorescence of MBTP-PA. Whenfw
increased from 40% to 50%, the PL intensity increased sharply,
demonstrating AIE characteristics. However, the PL intensity of
MBTP-PAdecreasedwhen fw exceeded80%.
TobetterunderstandthePLchangesofMBTP-PAaggregates,
we measured the particle size of MBTP-PA at varying water
contents. The results indicated that the average particle size at
50.36 nm (fw = 80%) was smaller than that at 224.6 nm (fw =
50%). The smaller particle size indicates that the eÔ¨Äective ag-
gregation of MBTP-PA was reduced, and the surface area was
increased, resulting in decreased PL intensity. In addition, the
absolute Ô¨Çuorescence quantum yield (–§F) of MBTP-PA ranged
from 0.4% in DMSO to 6.8% in solid Ô¨Ålm, explaining its AIE
properties(Table S1,SupportingInformation).Notably,duetoits
strongdonor-acceptorstructure,MBTP-PAexhibitspronounced
solvatochromism in solvents of varying polarity, including hex-
ane, 1,4-dioxane, ethyl acetate, and DMSO (FigureS4,S u p -
porting Information). To further investigate this donor-acceptor
structure, MBTP-PA was analyzed using density functional the-
ory (DFT) calculations. The geometries of MBTP-PA were opti-
mized using the M062x/6-31G** level (Figure1F). The delocal-
ized electron density of the highest occupied molecular orbital
(HOMO) was primarily concentrated in the dimethoxytripheny-
lamine segment. In contrast, the lowest unoccupied molecular
orbital(LUMO)wasconcentratedonthebenzo[1,2,5]thiadiazole
unit, demonstrating strong intramolecular charge transfer in
MBTP-PA. Furthermore, the energy level distribution between
singlet (S) and triplet (T) states was calculated (Figure1G). The
calculatedvaluesof ŒîES1-T1 and ŒîES1-T2 were0.75and ‚àí0.13eV,
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(2of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
Scheme 1.A) The thiol-yne click reaction between the covalent AIE photosensitizer, MBTP-PA, and thiols on proteins within cells. B) Schematic illus-
trationsofferroptosis-andpyroptosis-mediatedimmunotherapyfacilitatedbytheclickreactiontherapyandPDT,anditsinhibitoryeÔ¨Äectonmeta static
tumorsisdemonstratedbytheinjectionofMBTP-PAnanoparticlesintotheprimarytumor.
respectively, indicatingthatMBTP-PAispronetotriggerthein-
tersystem crossing process. These Ô¨Åndings suggest that MBTP-
PAiscapableofproducingreactiveoxygenspecies(ROS).
1.2.ExplorationofThiol-YneClickReactionofMBTP-PAwith
ThiolCompounds
After investigating its photophysical properties, we examined
the reactions of MBTP-PA with amino acids, peptides, and pro-
teinsthathaveamino,hydroxyl,andthiolgroups.MBTP-PAand
diÔ¨Äerent amino acids were added into a mixture of PBS and
THF (v/v= 1:1) with a pH 7.4, we found that L-lysine and L-
arginine (which contain amino group), as well as L-serine, and
L-tyrosine (which contain hydroxyl group), did not react with
MBTP-PA (Figure 2A,B). In contrast, Boc-Cys-OMe, Cys, and
GSH,whichcontainthiolgroups,reactedeÔ¨ÉcientlywithMBTP-
PA (Figure2C;F i g u r e sS5‚ÄìS8, Supporting Information). These
results demonstrate that MBTP-PA possesses high selectivity in
itsreactionwiththiolsubstances.Furthermore,bovineserumal-
bumin(BSA)waschosenasamodelproteintoverifythepoten-
tial reaction with MBTP-PA, given that BSA contains one non-
oxidizedcysteine(Cys-34).Inthiscontext,MBTP-PAwasreacted
withBSAinaPBSsolutioncontaining1%DMSO.Theresulting
MBTP-BSAproductwasanalyzedusingsodiumdodecylsulfate-
polyacrylamidegelelectrophoresis(SDS-PAGE).Asanticipated,
MBTP-BSA exhibited signiÔ¨Åcant Ô¨Çuorescence under UV radia-
tion(Figure 2D),whileBSAalonedidnotemitanyÔ¨Çuorescence.
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(3of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
Figure 1.A) Synthesis of the photosensitizer MBTP-PA. B) UV‚Äìvis spectrum of MBTP-PA in DMSO solution. C) Normalized photoluminescence (PL)
spectra of MBTP-PA in DMSO solution and its solid Ô¨Ålm. D) PL spectra of MBTP-PA in DMSO solutions with varying water volume fractions (fw).
E) Plots showing the ratio of I/I0, as a function of the DMSO/water mixture composition, where I represent the Ô¨Çuorescent intensity and I0 is the
minimum intensity. Inset: the size distribution of MBTP-PA in DMSO with 50% and 80% water fraction. F) LUMO and HOMO wave functions for the
geometricalstructuresofMBTP-PAoptimizedbyM062x/6-31G **.G)Singletandtripletenergylevelsandthe ŒîEST valuesofMBTP-PA.
Therefore, MBTP-PA can eÔ¨Äectively label proteins containing
thiolgroupswithouttheneedforcatalysts.
1.3.AnalysisofROSGenerationAbilityandSpecies
To evaluate changes in ROS generation before and after MBTP-
PAinteractswithcellularsubstances,weassessedtheROSgen-
eration capacity and analyzed the ROS species of MBTP-PA,
MBTP-BSA, MBTP-PA+BSA, MBTP-A, and Chlorin e6 (Ce6).
We used 2,7-dichlorodihydroÔ¨Çuorescein (DCFH), a commercial
indicator that detects various types of ROS, as a reporter for
ROS activity. As illustrated inFigures 3A and S9 (Supporting
Information), the PL intensity of the DCFH solution contain-
ingphotosensitizerssigniÔ¨Åcantlyincreasedwithprolongedwhite
light irradiation time (10 mW cm‚àí2). The rates of PL inten-
sity growth were ranked as follows: MBTP-PA+BSA > MBTP-
PA > MBTP-BSA > MBTP-A > Ce6. These Ô¨Åndings reveal that
MBTP-PA has a greater ROS generation capacity than MBTP-
A and Ce6. Notably, the ROS production rate decreased after
MBTP-PA reacted with BSA, likely due to the formation of
MBTP-BSA.
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(4of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
Figure2. A,B)ReactionsofMBTP-PAwithaminoacidscontaining(A)aminogroupsand(B)hydroxylgroupsinamixtureofPBSandTHF(v/v =1:1)
withapH7.4.Inset:photographsofthinlayerchromatography(TLC)plate.‚ÄúS‚ÄùindicatesthesubstrateMBTP-PA,‚ÄúP‚Äùmarksthereactionsolutionpoin t,
and ‚ÄúM‚Äù denotes the mixing pointsof MBTP-PA and P. C) Reactions of MBTP-PA with N-(tert-butoxycarbonyl)-L-cysteine methyl ester (Boc-Cys-OMe),
cysteine (Cys), and glutathione (GSH) in a mixture of PBS and THF (v/v= 1:1) with a pH 7.4. D) Schematic diagram of MBTP-PA reacting with BSA
(left)andwesternblotimagesforMBTP-BSA(right).
To identify the type of ROS generated by MBTP-PA, dihy-
drorhodamine 123 (DHR123) and hydroxyphenyl Ô¨Çuorescein
(HPF) were applied as indicators for superoxide radical (O2
‚àí‚Ä¢)
and hydroxyl radical (HO¬∑), respectively. This approach allowed
ustocharacterizethephotosensitizers‚ÄôcapacitytoproduceType
I ROS. As shown in Figures3Band S10(Supporting Informa-
tion),thePLintensityoftheseindicatorsvariedwithlightirradia-
tiontime.TheproductionrateofO 2
‚àí‚Ä¢ followedtheorder:MBTP-
PA+BSA>MBTP-PA>MBTP-BSA>MBTP-A>Ce6,whilethe
production rate of HO¬∑ was ranked as follows: MBTP-PA+BSA
>Ce6>MBTP-PA ‚âà MBTP-BSA>MBTP-A(Figure 3C;Figure
S11,SupportingInformation).TheseresultsindicatethatMBTP-
PAexhibitsastrongerabilitytoproduceTypeIROSthanMBTP-
A for both O2
‚àí‚Ä¢ and HO¬∑, with a notable decrease in the pro-
duction rate of Type I ROS observed after MBTP-PA reacts with
BSA. In addition, 5-tert-butoxycarbonyl5-methyl-1-pyrroline N-
oxide (BMPO) was used to capture HO¬∑ and O2
‚àí‚Ä¢ generated by
MBTP-PAandMBTP-Aunderwhitelight(Figure S12,Support-
ingInformation).Thecharacteristicsignalofelectronparamag-
neticresonance(EPR)wasdetected,providingadditionalconÔ¨År-
mationoftheTypeIROSgeneration.
On the other hand, 9,10-anthracenediyl-bis(methylene) di-
malonic acid (ABDA) was utilized as a1O2 indicator to de-
termine whether Type II ROS was generated. As shown in
Figures 4D and S13(Supporting Information), the decompo-
sition rate of ABDA across all groups, except for Ce6, aligned
closely with that of the control group, and no signiÔ¨Åcant EPR
signal was detected, when the1O2 was captured using 2,2,6,6-
tetramethylpiperidine(TEMP)(Figure S14,SupportingInforma-
tion), indicating that MBTB-PA did not produce1O2. Collec-
tively, these results aÔ¨Érm that MBTP-PA functions as a Type I
photosensitizer.
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(5of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
Figure 3.A‚ÄìC) Change of PL intensities of (A) 10Œºm DCFH, (B) 10Œºm DHR123, and (C) 5Œºm HPF in the presence of MBTP-PA, MBTP-BSA, MBTP-
PA+BSA,MBTP-A,andCe6inPBScontaining1%DMSO,asafunctionoflightirradiationtime.D)Decompositionratesof50 ŒºmABDAinthepresenceof
MBTP-PA,MBTP-BSA,MBTP-PA +BSA,MBTP-A,andCe6inPBSwith1%DMSOvaryingwithlightirradiationtime.AandA 0 representtheabsorbances
ofABDAbeforeandafterirradiation,respectively.
1.4.FluorescenceImagingandAntitumorActivityAnalysis
Following our investigation of the ROS production capacity of
MBTP-PA, we further examined its localization and anti-tumor
activity within cells. In order to highlight the characteristics of
the covalent photosensitizer MBTP-PA, we selected MBTP-A as
acontrol.First,weexaminedthecellularuptakeratesandreten-
tion time of both MBTP-PA and MBTP-A. As shown in Figures
S15andS16(SupportingInformation),4T1cellswereincubated
either with MBTP-PA or MBTP-A, and confocal laser scanning
microscopy (CLSM) was employed to capture images at various
time points. By analyzing the mean Ô¨Çuorescence intensity in
the cells, we found that the intracellular accumulation of both
compoundsincreasedovertime,withMBTP-Aenteringthecells
more rapidly than MBTP-PA. After 24 h of incubation, we re-
placed the medium to observe the change in intracellular Ô¨Çuo-
rescenceintensity.AsshowninFigure S17(SupportingInforma-
tion),MBTP-PAexhibitedalongerretentiontimeofintracellular
Ô¨ÇuorescencecomparedtoMBTP-A,indicatingthatcovalentpho-
tosensitizershavesuperiorretentionincells.
TofurtherelucidatethediÔ¨Äerencesinintracellulardistribution
between MBTP-A and MBTP-PA, we conducted co-localization
experiments using commercial organelle biomarkers. The re-
sults revealed that Pearson‚Äôs correlation coeÔ¨Écient of 0.87 be-
tween MBTP-A and Lyso-Tracker Green, indicating that MBTP-
A predominantly localized in lysosomes (Figure4A). In con-
trast,MBTP-PAshowedahighdegreeofoverlapwithER-Tracker
Green, yielding the Pearson‚Äôs correlation coeÔ¨Écient of 0.91,
compared to lower correlations with Mito-Tracker Green, Lyso-
TrackerGreen,andBodipy(Figure 4B).
Subsequently, we evaluated the tumor-killing eÔ¨Écacy of
MBTP-PA in both normoxic and hypoxic conditions, leveraging
itsrobustROSgenerationcapacityofandchemicalreactivity.In
the absence of white light irradiation, over 50% of MBTP-PA-
stained 4T1 cells were killed at concentrations exceeding 8Œºm
(Figure 4C). However, MBTP-PA maintained over 80% of cell
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(6of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
Figure 4.A,B) Colocalization images of 4T1 cells co-stained with (A) MBTP-A or (B) MBTP-PA and Lyso-Tracker Green, Mito-Tracker Green, Bodipy or
ER-Tracker Green. C,D) Cell viabilities of 4T1 cells were assessed under (C) in normoxic (21% O2) or (D) hypoxia (0.1% O2) conditions after exposure
to varying concentrations of MBTP-PA with or without light irradiation (30 mW cm‚àí2) for 30 min. E) Western blot analysis of 4T1 cells incubated with
MBTP-A or MBTP-PA, captured under a bright Ô¨Åeld (using Coomassie blue staining) and UV light. F,G) ROS generation analyses using the indicator
DCFH-DA in 4T1 cells F) incubated with 32Œºm MBTP-PA or MBTP-A in normoxia or hypoxia for 48 h, or G) incubated with 5Œºm MBTP-PA or MBTP-A
inthedarkfor24h,followedbyirradiationwithwhitelight(30mWcm ‚àí2)for5min.Thewavelengthofwhitelightis400‚Äì1000nm.
viability in normal L929 cells at concentrations below 8Œºm
(Figure S18, Supporting Information). Under white light expo-
sure, the cytotoxic eÔ¨Äect of MBTP-PA on 4T1 cells was further
signiÔ¨Åed.AlthoughMBTP-Aexhibitedanobviousphotodynamic
antitumoreÔ¨Äect,itseÔ¨Écacywasdramaticallydiminishedorren-
dered ineÔ¨Äective in hypoxia conditions. In contrast, MBTP-PA
retained its killing eÔ¨Äect (Figure4D), attributed to its reaction
withthiolgroups.ToconÔ¨Årmthesebiologicalreactionsoccurring
incells,welysedtheMBTP-PA-treated4T1cellsandperformed
Westernblotanalyses.AsdepictedinFigure 4E,distinctÔ¨Çuores-
centproteinbandswereobservedintheMBTP-PAgroup,butnot
intheMBTP-Agroup,indicatingthatMBTP-PAreactedwithin-
tracellularproteins.Inaddition,weusedDCFH-DAtoassessthe
intracellularoxidationlevels.Intheabsenceoflight,greenÔ¨Çuo-
rescencefromDCFwasdetectedinthecellstreatedwithMBTP-
PA under both normoxia and hypoxia conditions, but MBTP-A
did not produce such Ô¨Çuorescence (Figure4F). The results sug-
gestedthatMBTP-PAinducedintracellularoxidativestressbyde-
pleting reductive substances. For the cells incubated by MBTP-
PA or MBTP-A illuminated with white light (30 mW cm‚àí2)f o r
5min,thegreenÔ¨ÇuorescencesignalsfromDCFwereobservedin
bothgroups(Figure 4G),indicatingthatMBTP-AandMBTP-PA
generated ROS in cells under white light. The substantial ROS
production by MBTP-A and MBTP-PA contributed to the eÔ¨Äec-
tivekillingoftumorcells.
1.5.ResearchontheMechanismofCellDeath
The reaction of covalent photosensitizers MBTP-PA with thiol
compounds induced intracellular oxidative stress. Previous
studies have shown that redox imbalance is associated with
ferroptosis.[48,49] Therefore, we investigated the ferroptosis trig-
gered by MBTP-PA. GSH is a critical reducing agent that main-
tains the redox balance in cells. Our analysis revealed that the
intracellular GSH levels of MBTP-PA and MBTP-PA+Lg r o u p s
were lower compared to the control group (Figure5A). This re-
ductionwasattributedtotheconsumptionofGSHandthesub-
sequent generation of substantial amounts of ROS under white
light.Moreover,wecharacterizedthelevelsofGPx4proteinand
lipidperoxides,whicharethekeyindicatorsofferroptosis.West-
ernblotanalysisrevealedadecreaseinGPx4expressioninboth
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(7of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
Figure5. A)RelativeGSHcontentincellstreatedwithMBTP-PAandMBTP-PA +L.B)WesternblotassayofGPx4expression,C)Lipidperoxidationassay
measuringMDAlevelsin4T1cellssubjectedtovarioustreatments.D)Anti-tumoractivityofMBTP-PAinthepresenceofferrostatin-1.E)Morphologi cal
changesincellsacrossdiÔ¨Äerenttreatmentgroups.F‚ÄìH)SecretionlevelsofIL-18(F),IL-1 ùõΩ(G),andLDHrelease(H)in4T1cellstreatedwithMBTP-PA
andMBTP-PA+L.I)WesternblotanalysisofGSDMDandcaspase-1cleavage.J,K)ImmunoÔ¨ÇuorescentstainingshowingJ)CRTand(K)HMGB-1in4T1
cellsaftertreatmentwithMBTP-PAorMBTAP-PA +L.Datawerepresentedasmeans ¬±SD.n=3,*p<0.05,**p<0.01,*** p<0.001.
MBTP-PAandMBTP-PA +Lgroups(Figure 5B).Lipidperoxida-
tion assays indicated that the level of malondialdehyde (MDA),
a byproduct of oxidation, in the MBTP-PA group was compa-
rable to that of the control group. However, after the cells un-
derwent PDT, the MBTP-PA+L group exhibited signiÔ¨Åcantly el-
evated MDA levels compared to the other groups (Figure5C),
suggestingthatMBTP-PAinducestumorcelldeathviaferropto-
sis under white light irradiation. Meanwhile, the anti-tumor ac-
tivityofMBTP-PAwasinhibitedinthepresenceofferrostatin-1
(Figure5D),yetitstillshowedanotableanti-tumoreÔ¨Äect.Wehy-
pothesized that the antitumor activity of MBTP-PA is not solely
dependentontheferroptosis.Furthermore,weobservedthatthe
cellsintheMBTP-PAgroupatahighconcentrationof32 Œºm,as
wellasthoseintheMBTP-PA +Lgroup,exhibitedfoamingbehav-
ior(Figure 5E;Figure S19,SupportingInformation),suggesting
thatthesecellsmaybeundergoingpyroptosis. [50,51]
To validate our hypothesis, we assessed the factors associated
withpyroptosis.TheresultsrevealedthatinÔ¨Çammatorycytokines
(IL-1ùõΩandIL-18)andlactatedehydrogenase(LDH)werereleased
in the treatment group (Figure5F‚ÄìH). In addition, pyroptosis-
related proteins were analyzed. Notably, the levels of GSDMD
andpro-caspase-1weresigniÔ¨ÅcantlyreducedintheMBTP-PA +L
group,whilethelevelsofGSDMD-Nandcleaved-caspase-1were
increased(Figure 5I).TheseresultsindicatethatMBTP-PAgen-
erates ROS upon light irradiation, which activates caspase-1
withinthecells.ThisactivationleadstothecleavageofGSDMD
intoitsactiveGSDMD-Nfragments,whichsubsequentlytranslo-
cate to the cell membrane, forming pores to induce pyroptosis.
Next, we veriÔ¨Åed pyroptosis-mediated immunogenic cell death
(ICD)bydetectingcalreticulin(CRT)andHGMB-1biomarkers.
As shown in Figure5J,K, the exposure of CRT in MBTP-PA-
stained 4T1 cells signiÔ¨Åcantly increased under light irradiation.
Additionally,HMGB1wasfoundtomigratefromthenucleusto
the cytoplasm and ATP was signiÔ¨Åcantly released in the treat-
mentgroup(Figure S20,SupportingInformation).Theseresults
indicate that MBTP-PA eÔ¨Äectively induces the ICD, activating
the adaptive immune responses through pyroptosis upon light
irradiation.
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(8of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
Figure6. A)PreparationofMBTP-PA-NPs.B)SizedistributionanalysisandC)zetapotentialmeasurementofMBTP-PA-NPs.D)Stabilityassessmentof
MBTP-PA-NPsover30daysinH 2O.E)IntravenousinjectionofMBTP-PA-NPsinmice.F)TemporalchangesinÔ¨ÇuorescenceintensityofMBTP-PA-NPs
invariousorgansandtumors.G)HemolysisrateevaluationofMBTP-PA-NPs.
1.6.PreparationandCharacterizationofMBTP-PANanoparticles
To facilitate the in vivo application of MBTP-PA, DSPE-PEG2000
and DSPE-PEG2000-cRGD were utilized to encapsulate MBTP-
PA, because they have the advantages of increased drug circu-
lation time, enhanced stability, reduced protein adsorption, and
improvedencapsulationeÔ¨Éciency.[52] ThismethodformsMBTP-
PA nanoparticles (MBTP-PA-NPs) with an average particle size
of 110.9 nm and a zeta potential of‚àí33.4 eV (Figure 6A‚ÄìC).
and the encapsulation eÔ¨Éciency is 46.7%. The long-term parti-
clesizestabilitytestconÔ¨ÅrmedthatMBTP-PA-NPsremainstable
for up to 30 days (Figure6D; FigureS21, Supporting Informa-
tion). Photophysical characterization demonstrated that MBTP-
PA-NPs exhibit an absorption maximum of 472 nm, a maxi-
mum emission peak of 650 nm, and an absolute Ô¨Çuorescence
quantumyieldof6.4%(Figure S22,SupportingInformation).In
addition, cellular uptake and Ô¨Çuorescence colocalization imag-
ing showed that MBTP-PA-NPs entered cells more rapidly than
MBTP-PAandwerepredominantlylocalizedintheendoplasmic
reticulum (FiguresS23and S24, Supporting Information). Cell
viabilitytestsshowedthatthenanoparticlesexhibitedhighercy-
totoxicitytowardcancercellsthannormalcells(Figure S25,Sup-
portingInformation).
1.7.IntracellularDistributionandSafetyEvaluationof
MBTP-PA-NPsInVivo
Togainadeepunderstandingofthedistributionandmetabolism
of nanoparticles in vivo, MBTP-PA-NPs (11.67 mg kg‚àí1)w e r e
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(9of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
Figure7. A)Schematicdiagramofthetumortreatmentprocessinvivo.B)ChangesinbodyweightofmiceacrossdiÔ¨Äerenttreatmentgroupsovertime.
C) Volume changes of the primary tumor and D) distant tumor in tumor-bearing mice subjected to various treatments (n = 6). E and F) Photographs
of(E)theprimarytumorand(F)thedistanttumoronthe14thdayfollowingdiÔ¨Äerenttreatments.G)Weightsofprimaryanddistanttumoronthe14th
day.Datawaspresentedmeans ¬±SD(n =6).*p<0.05,**p<0.01,*** p<0.001.Thewavelengthofwhitelightis400‚Äì1000nm.
injected into tumor-bearing mice via the tail vein (Figure6E),
and their distribution was monitored using Ô¨Çuorescence mi-
croscopy. At 24 h post-injection, the Ô¨Çuorescence intensity was
notably higher in the liver, lung, and tumor, indicating that the
MBTP-PA-NPs primarily accumulated in these organs and tis-
sues (Figure6F). By 48 h, the Ô¨Çuorescence intensity in the liver
and lung decreased and increased in the tumor. This suggests
thattheMBTP-PA-NPsundergometabolicprocessingpreferen-
tial accumulation at the tumor site. After 72 h, the Ô¨Çuorescence
intensity in the liver, lung, and tumor gradually diminished.
Furthermore, following the injection of MBTP-PA-NPs (11.67
mgkg‚àí1)intonormalmice,weassessedvariousbloodroutinein-
dicatorsandhemolysisrate.AsshowninFigure 6GandFigures
S26andS27(SupportingInformation),nosigniÔ¨Åcanthemolysis
wasobservedatconcentrationsbelow128 ŒºgmL‚àí1(Theredinthe
supernatantisthecoloroftheMBTP-PA-NPsitselfinFigure 6G),
andtherewerenonotablediÔ¨ÄerencesinÔ¨Åfteenbloodindicators
comparedtothecontrolgroup.TheseresultsindicatethatMBTP-
PA-NPsexhibitminimaltoxicityattheseconcentrations.
1.8.SynergisticTreatmentofPrimaryTumorandDistantTumor
AfterconÔ¨ÅrmingthesafetyofMBTP-PA-NPs,weappliedMBTP-
PA-NPsinphotodynamicimmunotherapytotargetandsuppress
distant tumors in a bilateral 4T1 tumor model. As shown in
Figure 7A, MBTP-PA-NPs (3.5 mg kg‚àí1) were injected into the
primarytumor(leftside),followedbyirradiationwithwhitelight
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(10of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
Figure 8.A) Histological H&E staining of tumor and muscle tissues after completing the in vivo antitumor assay. Scale bar: 100Œºm. B) Fluorescent
stainingofTUNEL,Ki67,CRT,andHMGB-1intumortissuessubjectedtodiÔ¨Äerenttreatments.C)ProportionsofCD80 + andCD86+ expressioninspleen
samples.D)ProportionsofinÔ¨ÅltratingTlymphocytes(CD8 + andCD4+)indistanttumors,measuredacrossdiÔ¨Äerenttreatmentgroups.
(150mWcm‚àí2)for30minaftera24hincubationperiod.Wethen
monitoredandcollectedgrowthdataforbothprimaryanddistant
tumors(rightside)inmice.TheresultsshowednosigniÔ¨Åcantdif-
ference in the weight of mice among all groups (Figure7B). By
analyzingthetumorvolumeandweight(Figure 7C‚ÄìG),wefound
thatMBTP-PA-NPssigniÔ¨Åcantlyinhibitedthegrowthofthepri-
mary tumor. Notably, the MBTP-PA-NPs+L group showed even
greateranti-tumoractivitycomparedtoMBTP-PA-NPsalone,at-
tributed to the synergistic eÔ¨Äects of intracellular reactions and
PDT. Regarding the distant tumors, their growth was signiÔ¨Å-
cantly suppressed in the MBTP-PA-NPs+L group, likely due to
theimmuneresponseelicitedbythistherapeuticapproach.
Inaddition,hematoxylinandeosin(H&E)tumorstainingwas
conducted to assess cell morphology. Notable voids and kary-
opyknosis were observed in the primary tumors treated with
MBTP-PA-NPs and the distant tumors treated with the MBTP-
PA-NPs+Lgroup.IntheprimarytumoroftheMBTP-PA-NPs +L
group,H&Estainingoftheadjacentmuscletissuesrevealednor-
mal histological characteristics (Figure 8A). Additionally, H&E
staining of key organs in the treatment groups showed no sig-
niÔ¨Åcantdamage,demonstratinggoodbiosafetyofMBTP-PA-NPs
(FigureS28,SupportingInformation).Furthermore,theTUNEL
staining and Ki67 analysis of the distant tumor revealed that
manytumorcelldeathsandsigniÔ¨Åcantlyinhibitedcellprolifera-
tioninthetreatmentgroup,corroboratingtheÔ¨Åndingsfromthe
H&Estaining(Figure 8B).
To investigate the immunological mechanisms underlying
pyroptosis-mediated photoimmunotherapy induced by MBTP-
PA-NPs, we conducted immunological analyses on the spleen
and distant tumors four days post-treatment. Staining of CRT
and HMGB1 in distant tumors showed the expression of both
markers in the MBTP-PA-NPs and MBTP-PA-NPs+Lg r o u p s
(Figure8B). Subsequently, we analyzed the presence of mature
dendritic cells (DCs) and activated immune cells. In the spleen,
the proportion of mature DCs (CD86+,C D 8 0+)w a sf o u n dt o
be79.01%and87.98%inMBTP-PA-NPsandMBTP-PA-NPs +L
groups, respectively, much higher than those in the control
group,indicatingthatboththereactiveactivityandthephotody-
namic eÔ¨Äects of MBTP-PA contribute to the maturation of DCs
(Figure8C).
To further investigate whether mature DCs can activate dif-
ferent types of T cells (CD4+ and CD8+), we analyzed the lev-
els of these T cell subsets in distant tumors using Ô¨Çow cytome-
try. The results showed a signiÔ¨Åcant increase in the proportion
of eÔ¨Äector CD4+ T cells in the MBTP-PA-NPs+L group, while
the proportion of CD8+ did not obviously change (FigureS29,
Supporting Information). These Ô¨Åndings indicate that CD4+ T
cells play a pivotal role in photodynamic immunotherapy. This
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(11of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
inhibitory eÔ¨Äect on distal tumors could be attributed to the fact
thatCD4+ TcellsassistCD8 + Tcellstoinhibittumorgrowth,and
CD4+ TcellshaveaninhibitingeÔ¨Äectontumors. [53,54] Thissug-
gests that MBTP-PA-NPs-mediated PDT can eÔ¨Äectively activate
immuneresponses,highlightingitspotentialinimmunotherapy
(Figure8D).
2.Conclusion
This study successfully integrates a covalent warhead, alky-
namide into an AIE type I photosensitizer, culminating in the
development of the novel targeted endoplasmic reticulum cova-
lent photosensitizer, MBTP-PA. It facilitates ferroptosis and py-
roptosis, enabling a synergistic approach to photodynamic im-
munotherapy. It also demonstrates its covalent capability by ef-
Ô¨Åciently reacting with thiol compounds such as Cys, GSH, and
BSA. Additionally, it outperforms the non-covalent photosensi-
tizer MBTP-A in terms of cellular retention and the induction
of intracellular oxidative stress, which help alleviate tumor hy-
poxia and enhance the eÔ¨Écacy of photodynamic therapy. More
importantly,theMBTP-PA-NPsnotonlypromoteferroptosisand
pyroptosisthroughthiol-ynereactiontherapyandphotodynamic
therapy,butalsoinitiatetheICD.Thiswasvalidatedthroughanti-
tumorexperimentsinabilateral4T1tumormodel,demonstrat-
ing the eÔ¨Äective elimination of primary tumors and signiÔ¨Åcant
suppression of distant tumors. And MBTP-PA-NPs have no ap-
parent damage to normal tissues, showing excellent biosafety.
Overall, this research not only introduces a new class of co-
valent photosensitizers, but also provides a framework for de-
veloping advanced therapeutic materials to improve anti-tumor
strategies.
3.ExperimentalSection
SynthesisofMBTP-PA : MBTP-A(0.4mmol,212mg),EDC(0.8mmol,
124 mg), and DCM (12.0 mL) were placed into a 50 mL round bottom
Ô¨Çask. Propiolic acid (0.6 mmol, 42 mg) was then added slowly to the
mixture in the ice water bath. Next, the solution of DMAP (0.02 mmol,
2.4 mg) in DCM (8.0 mL) was added dropwise into the above mixture.
Then, the temperature was spontaneously warmed to room-temperature
and the reaction was stirred for 3 h (the progress of the reaction was
monitoredbyTLC).Aftercompletionofthereaction,thereactionwasex-
tracted three times with water and DCM. The organic phase was dried
with anhydrous sodium sulfate. The DCM was removed under vacuum
and the resultant residue was puriÔ¨Åed by Ô¨Çash chromatography on sil-
ica gel to get the red solid MBTP-PA in 55% yield (eluent: DCM).1H
NMR (400 MHz, CDCl3) ùõø7.97 (d,J = 8.0 Hz, 2H), 7.81 (d,J = 8.0 Hz,
2H), 7.76‚Äì7.68 (m, 5H), 7.14 (d,J = 12.0 Hz, 4H), 7.06 (d,J = 8.0 Hz,
2H), 6.87 (d,J = 8.0 Hz, 2H), 3.81 (s, 6H), 2.97 (s, 1H).13CN M R
(100 MHz, CDCl3) ùõø156.1, 154.1, 153.7, 149.6, 149.0, 140.5, 134.4,
133.2, 129.9, 129.8, 127.1, 126.8, 120.0, 119.6, 114.8, 74.4, 55.5. HRMS
(MALDI-TOF)m/z[M +Na]+ calcdforC 35H26N4O3SNa+ 605.1618,found
605.1625.
Intracellular Reaction: 4T1 cells were seeded in a 6-well plate at 6√ó
105 cells per well and incubated for 12 h. The medium was then replaced
with fresh DMEM (10% FBS) containing MBTP-A or MBTP-PA (100Œºm).
After 24 h of incubation with the compounds, the medium was removed,
andthecellswerewashedthreetimeswithPBS.Thecellswerecollected,
lysedonicefor15minusinglysisbuÔ¨Äer,andcentrifugedat12000rpmfor
1 5m i na t4¬∞C. The supernatant was collected, boiled, and used for pro-
tein electrophoresis. Protein concentration was determined using a BCA
reagent.Proteinswereseparatedby10%SDS-PAGE,andthebandswere
visualizedusingaUVmodeofgelimager.Theproteinbandswerestained
with Coomassie Brilliant Blue, washed with water Ô¨Åve times, and imaged
withagelimager.
Preparation of Nanoparticles: MBTP-PA (1.0 mg), DSPE-PEG2000-
cRGD (1.5 mg), and DSPE-PEG2000 (1.5 mg) were dissolved in 1 mL of
THF under ultrasonic dispersion. Then the homogeneous mixture was
quickly added to ultrapure water (10 mL). After sonication using a probe
sonicator for 3 min, the mixture was collected and concentrated by cen-
trifugal Ô¨Ålters for further use. The obtained nanoparticles were stored at
4 ¬∞C.
Establishment of 4T1 Tumor Models: The Animal Ethics Committee
of the South China Agricultural University granted approval for all ani-
malexperimentprotocols(approvalnumber:2023d098).Abilateraltumor
mousemodelwasinitiatedbysubcutaneouslyinjecting4T1cellsintothe
left and right hips of mice at‚àí8a n d‚àí2 days prior to treatment, respec-
tively,toinduceprimaryanddistanttumors.
In Vivo Biodistribution Evaluation: The mice bearing 4T1 tumors were
administered with MBTP-PA-NPs (11.67 mg kg‚àí1) through tail-vein in-
jection (n = 3). After injection for several times (24, 48, 72, and 96 h),
these mice were euthanized to extract heart, liver, spleen, lung, kidney,
and tumor. Fluorescence imaging of these tissues were conducted using
animagingsystem.
InVivoTherapeuticEÔ¨ÉcacyEvaluation : The4T1tumor-bearingBALB/c
mice were randomly divided into four groups (n = 6). The mice in each
group were systemically administrated with PBS or MBTP-PA-NPs (3.5
mg kg‚àí1) through intratumor injection. After administrated for 24 h,
the primary tumors of mice were exposed under white light irradiation
(150mWcm ‚àí2)for30min.AfterdiÔ¨Äerenttreatments,thetherapeuticeÔ¨É-
cacieswereevaluatedbymeasuringthesizesofbothprimaryanddistant
tumors every 2 days for 14 days. Tumor volumes (V) were calculated ac-
cording to the formula: V= (tumor length)√ó (tumor width)2/2. After 14
daysoftreatments,themiceineachgroupwereeuthanized,andboththe
primary and distant tumors were extracted to weigh. The wavelength of
whitelightwas400‚Äì1000nm.
SupportingInformation
SupportingInformationisavailablefromtheWileyOnlineLibraryorfrom
theauthor.
Acknowledgements
B.W. and G.Z. contributed equally to this work. This work was Ô¨Å-
nancially supported by the Innovation and Technology Commission of
Hong Kong (ITC-CNERC14SC01 and ITCPD/17-9), the Research Grants
Council of Hong Kong (16303221 and C6014-20 W), the Fund of
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(12of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
Guangdong Provincial Key Laboratory of Luminescence from Molec-
ular Aggregates (2023B1212060003), the Shenzhen Key Laboratory of
Functional Aggregate Materials (ZDSYS20211021111400001), and the
Science Technology Innovation Commission of Shenzhen Municipality
(KQTD20210811090142053andJCYJ2022081810-3007014).
ConÔ¨ÇictofInterest
TheauthorsdeclarenoconÔ¨Çictofinterest.
DataAvailabilityStatement
The data that support the Ô¨Åndings of this study are available from the
correspondingauthoruponreasonablerequest.
Keywords
aggregation-induced emission, covalent photosensitizer, ferroptosis and
pyroptosis,intracellularclickreactions,photodynamicimmunotherapy
Received:October14,2024
Revised:February12,2025
Publishedonline:February23,2025
[1] I.Mellman,G.Coukos,G.DranoÔ¨Ä, Nature2011,480,480.
[2] S.L.Topalian,J.M.Taube,D.M.Pardoll, Science2020,367,182.
[3] Y.Tang,H.K.Bisoyi,X.M.Chen,Z.Liu,X.Chen,S.Zhang,Q.Li, Adv.
Mater.2023,35,2300232.
[4] L.Zhang,S.C.Wan,J.Zhang,M.J.Zhang,Q.C.Yang,B.Zhang,W.
Y .W a n g ,J .S u n ,R .T .K .K w o k ,J .W .Y .L a m ,H .D e n g ,Z .J .S u n ,B .Z .
Tang,J.Am. Chem. Soc.2023,145,17689.
[5] M. Wen, J. Ouyang, C. Wei, H. Li, W. Chen, Y. N. Liu,Angew. Chem.,
Int. Ed.2019,58,17425.
[6] Q. Chen, J. Chen, Z. Yang, J. Xu, L. Xu, C. Liang, X. Han, Z. Liu,Adv.
Mater.2019,31,1802228.
[7] J.Qi, F. Jin,Y. You, Y. Du, D. Liu, X.Xu, J.Wang, L. Zhu,M. Chen,G.
Shu,L.Wu,J.Ji,Y.Du, Nat. Commun.2021,12,4755.
[8] O. Kepp, L. Galluzzi, I. Martins, F. Schlemmer, S. Adjemian, M.
Michaud,A.Q.Sukkurwala,L.Menger,L.Zitvogel,G.Kroemer, Can-
cer Metast. Rev.2011,30,61.
[9] C. Chen, X. Ni, S. Jia, Y. Liang, X. Wu, D. Kong, D. Ding,Adv. Mater.
2019,31,1904914.
[10] L. Galluzzi, A. Buqu√©, O. Kepp, L. Zitvogel, G. Kroemer,Nat. Rev.
Immunol.2017,17,97.
[11] M. Obeid, A. Tesniere, F. Ghiringhelli, G. M. Fimia, L. Apetoh, J.
L. Perfettini, M. Castedo, G. Mignot, T. Panaretakis, N. Casares, D.
M√©tivier,N.Larochette,P.vanEndert,F.Ciccosanti,M.Piacentini,L.
Zitvogel,G.Kroemer, Nat. Med.2007,13,54.
[12] A.P.Castano,P.Mroz,M.R.Hamblin, Nat.Rev.Cancer 2006,6,535.
[13] Z. Deng, N. Wang, Y. Liu, Z. Xu, Z. Wang, T. C. Lau, G. Zhu,J. Am.
Chem. Soc.2020,142,7803.
[14] X. Su, W. J. Wang, Q. Cao, H. Zhang, B. Liu, Y. Ling, X. Zhou, Z. W.
Mao,Angew. Chem., Int. Ed.2022,61,202115800.
[15] X. Zhao, J. Liu, J. Fan, H. Chao, X. Peng,C h e m .S o c .R e v .2021, 50,
4185.
[16] S.Liu,B.Wang,Y.Yu,Y.Liu,Z.Zhuang,Z.Zhao,G.Feng,A.Qin,B.
Z.Tang, ACS Nano2022,16,9130.
[17] B. Wang, S. Liu, X. Liu, R. Hu, A. Qin, B. Z. Tang,Adv. Healthcare
Mater.2021,10,2101067.
[18] Z.Zhuang,J.Li,P.Shen,Z.Zhao,B.Z.Tang, Aggregate2024,5,e540.
[19] B.Wang,L.Wang,X.Liu,J.Zhu,R.Hu,A.Qin,B.Z.Tang, ACSAppl.
Bio Mater.2022,5,4955.
[20] S.Chen,B.Li,Y.Yue,Z.Li,L.Qiao,G.Qi,Y.Ping,B.Liu, Adv.Mater.
2024,36,2404296.
[21] K.X.T eng,D.Zhang,B.K.Liu,Z.F .Liu,L.Y .Niu,Q.Z.Y ang, Angew.
Chem., Int. Ed.2024,63,202318783.
[22] J. Qi, S. Jia, X. Kang, X. Wu, Y. Hong, K. Shan, X. Kong, Z. Wang, D.
Ding,Adv. Mater.2022,34,2203309.
[23] R.Zheng,C.Huang,H.Zhou,L.Zhao,Q.Li,G.Chen,L.Zhao,S.Li,
Aggregate2024,5,e610.
[24] X. Kang, Y. Zhang, J. Song, L. Wang, W. Li, J. Qi, B. Z. Tang,Nat.
Commun.2023,14,5216.
[25] J. Li, H. Gao, R. Liu, C. Chen, S. Zeng, Q. Liu, D. Ding,Sci. China
Chem.2020,63,1428.
[26] K. Lu, C. He, N. Guo, C. Chan, K. Ni, R. R. Weichselbaum, W. Lin,J.
Am. Chem. Soc.2016,138,12502.
[27] J. Xu, L. Xu, C. Wang, R. Yang, Q. Zhuang, X. Han, Z. Dong, W. Zhu,
R.Peng,Z.Liu, ACS Nano2017,11,4463.
[28] R. Xu, Q. Shen, P. Zhang, Z. Wang, Y. Xu, L. Meng, D. Dang,Adv.
Mater.2024,36,2402434.
[ 2 9 ] G .Y a n g ,L .X u ,Y .C h a o ,J .X u ,X .S u n ,Y .W u ,R .P e n g ,Z .L i u ,Nat.
Commun.2017,8,902.
[30] Z.Chen,L.Liu,R.Liang,Z.Luo,H.He,Z.W u,H.Tian,M.Zheng,Y .
Ma,L.Cai, ACS Nano2018,12,8633.
[ 3 1 ] W .C h e n ,Z .W a n g ,M .T i a n ,G .H o n g ,Y .W u ,M .S u i ,M .C h e n ,J .A n ,
F.Song,X.Peng, J. Am. Chem. Soc.2023,145,8130.
[32] S. Liu, Y. Pei, Y. Sun, Z. Wang, H. Chen, D. Zhu, M. R. Bryce, B. Z.
Tang,Y.Chang, Aggregate2024,5,e547.
[33] T. Zhang, X. Yang, X. Ou, M. M. S. Lee, J. Zhang, C. Xu, X. Yu,
P. Gong, J. W. Y. Lam, P. Zhang, B. Z. Tang,Adv. Mater.2023, 35,
2303186.
[34] C. Zhang, W. J. Qin, X. F. Bai, X. Z. Zhang,Nano Today2020, 35,
100960.
[ 3 5 ] Y .T .F a n ,T .J .Z h o u ,P .F .C u i ,Y .J .H e ,X .C h a n g ,L .X i n g ,H .L .J i a n g ,
Adv. Funct. Mater.2019,29,1806708.
[36] L.Shi,P.Zhang,X.Liu,Y.Li,W.Wu,X.Gao,B.Liu, Adv.Mater. 2022,
34,2206659.
[37] L.Shi,W.Wu,Y.Duan,L.Xu,Y.Xu,L.Hou,X.Meng,X.Zhu,B.Liu,
Angew. Chem., Int. Ed.2020,59,19168.
[38] X.F u,A.Qin,B.Z.T ang, Aggregate2023,4,e350.
[39] J.C.Worch,A.P.Dove, Acc. Chem. Res.2022,55,2355.
[40] B. Wang, C. Li, D. He, K. Ding, Q. Tian, G. Feng, A. Qin, B. Z. Tang,
Small2024,20,2307309.
[41] Z. Liu, S. Liu, B. Liu, Q. Meng, M. Yuan, X. Ma, J. Wang, P. a. Ma, J.
Lin,Adv. Funct. Mater.2024,34,2407153.
[42] F.Hu,S.Xu,B.Liu, Adv. Mater.2018,30,1801350.
[43] M.M.S.Lee,D.M.Lin,J.H.C.Chau,E.Y.Yu,D.Ding,R.T.K.Kwok,
D.Wang,B.Z.Tang, ACS Nano2023,17,11039.
[44] J. Jia, Z. Ma, J. Zhuang, L. Huo, C. Zhou, N. Li, N. Zhao,Aggregate
2024,5,e516.
[45] Y.Wang,J.Liao,Y.Lyu,Q.Guo,Z.Zhu,X.Wu,J.Yu,Q.Wang,W.H.
Zhu,Adv. Funct. Mater.2023,33,2301692.
[46] S.Wang,C.Chen,J.Wu,J.Zhang,J.W.Y.Lam,H.Wang,L.Chen,B.
Z.Tang, Sci. China Chem.2022,65,870.
[47] Z. Liu, H. Zou, Z. Zhao, P. Zhang, G. G. Shan, R. T. K.
K w o k ,J .W .Y .L a m ,L .Z h e n g ,B .Z .T a n g ,ACS Nano 2019, 13,
11283.
[48] C. Liang, X. Zhang, M. Yang, X. Dong, Adv. Mater. 2019, 31,
1904197.
[49] Y.Wang,Z.Chen,J.Li,Y.Wen,J.Li,Y.Lv,Z.Pei,Y.Pei, Adv.Sci. 2024,
11,2306178.
[50] C. Lee, M. Park, W. C. B. Wijesinghe, S. Na, C. G. Lee, E. Hwang,
G. Yoon, J. K. Lee, D. H. Roh, Y. H. Kwon, J. Yang, S. A. Hughes,
J. E. Vince, J. K. Seo, D. Min, T. H. Kwon,Nat. Commun.2024, 15,
4025.
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(13of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
www.advancedsciencenews.com www.advmat.de
[51] Y .Chen,W .Li,S.Kwon,Y .W ang,Z.Li,Q.Hu,J.Am.Chem.Soc. 2023,
145,9815.
[52] C. Jing, I. O. Chukwunweike, H. Zhong-Bo, X. Jing,Curr. Pharm. De-
sign2015,21,1598.
[53] B.Kruse,A.C.Buzzai,N.Shridhar,A.D.Braun,S.Gellert,K.Knauth,
J.Pozniak,J.Peters,P.Dittmann,M.Mengoni,T.C.vanderSluis,S.
H√∂hn, A. Antoranz, A. Krone, Y. Fu, D. Yu, M. Essand, R. GeÔ¨Äers,
D. Mougiakakos, S. Kahlfu√ü, H. Kashkar, E. GaÔ¨Äal, F. M. Bosisio, O.
Bechter, F. Rambow, J. C. Marine, W. Kastenm√ºller, A. J. M√ºller, T.
T√ºting,Nature2023,618,1033.
[54] A. ¬¥Sledzi¬¥nska, M. Vila de Mucha, K. BergerhoÔ¨Ä, A. Hotblack,
D. F. Demane, E. Ghorani, A. U. Akarca, M. A. V. Marzolini,
I. Solomon, F. A. Vargas, M. Pule, M. Ono, B. Seddon, G.
Kassiotis, C. E. Ariyan, T. Korn, T. MaraÔ¨Åoti, G. M. Lord, H. Stauss,
R. G. Jenner, K. S. Peggs, S. A. Quezada, Immunity 2020, 52,
151.
Adv. Mater.2025,37,2415673 ¬©2025Wiley-VCHGmbH2415673(14of14)
 15214095, 2025, 13, Downloaded from https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202415673 by <Shibboleth>-member@library.princeton.edu, Wiley Online Library on [31/01/2026]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License